Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)
B. Vanhove, S. S. Marot, G. Evanno, I. Mallet, G. Rouvray, F. Shneiker, E. Mevel, C. Ciron, J. Rousse, P.-J. Royer, E. Lheriteau, F. Raffi, O. Duvaux, A.-G. Marcelin, V. Calvez
bioRxiv · Jan 26, 2022 · PreprintImmunology